Teva Pharmaceutical Industries Stock Analysis

TEVJF Stock  USD 17.19  2.49  16.94%   
Teva Pharmaceutical Industries is undervalued with Real Value of 18.92 and Hype Value of 17.19. The main objective of Teva Pharmaceutical pink sheet analysis is to determine its intrinsic value, which is an estimate of what Teva Pharmaceutical Industries is worth, separate from its market price. There are two main types of Teva Pharmaceutical's stock analysis: fundamental analysis and technical analysis.
The Teva Pharmaceutical pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Teva Pharmaceutical's ongoing operational relationships across important fundamental and technical indicators.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teva Pharmaceutical Industries. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.

Teva Pink Sheet Analysis Notes

The company has price-to-book ratio of 1.1. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Teva Pharmaceutical has Price/Earnings To Growth (PEG) ratio of 0.8. The entity recorded a loss per share of 0.56. The firm last dividend was issued on the 28th of November 2017. Teva Pharmaceutical had 2:1 split on the 11th of December 2002. Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel. TEVA PHARMACEUTICAL is traded on OTC Exchange in the United States.The quote for Teva Pharmaceutical Industries is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Teva Pharmaceutical Industries contact Kare Schultz at 972 3 914 8213 or learn more at https://www.tevapharm.com.

Teva Pharmaceutical Investment Alerts

Teva Pharmaceutical is way too risky over 90 days horizon
Teva Pharmaceutical appears to be risky and price may revert if volatility continues
The company reported the revenue of 14.93 B. Net Loss for the year was (2.41 B) with profit before overhead, payroll, taxes, and interest of 6.97 B.

Teva Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 10.99 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Teva Pharmaceutical's market, we take the total number of its shares issued and multiply it by Teva Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Teva Profitablity

The company has Profit Margin (PM) of (0.16) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.18 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.18.

Technical Drivers

As of the 16th of July 2024, Teva Pharmaceutical has the Variance of 28.08, risk adjusted performance of 0.0691, and Coefficient Of Variation of 1003.93. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Teva Pharmaceutical, as well as the relationship between them. Please validate Teva Pharmaceutical standard deviation, as well as the relationship between the maximum drawdown and kurtosis to decide if Teva Pharmaceutical is priced more or less accurately, providing market reflects its prevalent price of 17.19 per share. Given that Teva Pharmaceutical has information ratio of 0.0912, we advise you to double-check Teva Pharmaceutical Industries's current market performance to make sure the company can sustain itself at a future point.

Teva Pharmaceutical Price Movement Analysis

Execute Study
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Teva Pharmaceutical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Teva Pharmaceutical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Teva Pharmaceutical Predictive Daily Indicators

Teva Pharmaceutical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Teva Pharmaceutical pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Teva Pharmaceutical Forecast Models

Teva Pharmaceutical's time-series forecasting models are one of many Teva Pharmaceutical's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Teva Pharmaceutical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Teva Pink Sheet Analysis

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Teva Pharmaceutical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Teva shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Teva Pharmaceutical. By using and applying Teva Pink Sheet analysis, traders can create a robust methodology for identifying Teva entry and exit points for their positions.
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel. TEVA PHARMACEUTICAL is traded on OTC Exchange in the United States.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Teva Pharmaceutical to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio Manager Now

   

Portfolio Manager

State of the art Portfolio Manager to monitor and improve performance of your invested capital
All  Next Launch Module

Complementary Tools for Teva Pink Sheet analysis

When running Teva Pharmaceutical's price analysis, check to measure Teva Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharmaceutical is operating at the current time. Most of Teva Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Teva Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharmaceutical's price. Additionally, you may evaluate how the addition of Teva Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Global Correlations
Find global opportunities by holding instruments from different markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges